Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

YS Biopharma Co Ltd (YS)

  • Technical Exchange News
  • May 28, 2024, 07:07 UTC
  • 35
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: D. New value: YS Biopharma Co., Ltd. - Ordinary Shares.

Comment Full text

YS Biopharma Co Ltd (YS)

  • Technical Exchange News
  • May 28, 2024, 00:09 UTC
  • 34
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: YS Biopharma Co., Ltd. - Ordinary Shares.

Comment Full text

Finch Therapeutics Group Inc. (FNCH)

  • Technical Exchange News
  • May 28, 2024, 00:09 UTC
  • 32
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Finch Therapeutics Group, Inc. - Common Stock.

Comment Full text

Finch Therapeutics Group Inc. (FNCH)

  • Technical Exchange News
  • May 28, 2024, 00:09 UTC
  • 31
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Finch Therapeutics Group, Inc. - Common Stock.

Comment Full text

Finch Therapeutics Group Inc. (FNCH)

  • Technical Exchange News
  • May 28, 2024, 00:09 UTC
  • 31
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Finch Therapeutics Group, Inc. - Common Stock. New value: Finch Therapeutics Group, Inc. - Common Stock.

Comment Full text

YS Biopharma Co Ltd (YS)

  • Technical Exchange News
  • May 28, 2024, 00:09 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: D. New value: YS Biopharma Co., Ltd. - Ordinary Shares.

Comment Full text

YS Biopharma Co Ltd (YS)

  • Technical Exchange News
  • May 28, 2024, 00:09 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: YS Biopharma Co., Ltd. - Ordinary Shares. New value: YS Biopharma Co., Ltd. - Ordinary Shares.

Comment Full text

Finch Therapeutics Group Inc. (FNCH)

  • Technical Exchange News
  • May 25, 2024, 02:02 UTC
  • 41
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Evotec SE (EVO)

  • Technical Exchange News
  • May 25, 2024, 02:02 UTC
  • 35
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

Comment Full text

Finch Therapeutics Group Inc. (FNCH)

  • Technical Exchange News
  • May 24, 2024, 18:38 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 665
  • 666
  • 667
  • 668
  • 669
  • Next

Search

News categories

  • Technical Exchange News(11766)
  • Event(4289)
  • SEC News(235893)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(143359)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin